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Nfix belongs to a family of four highly conserved pro-
teins that act as transcriptional activators and/or re-
pressors of cellular and viral genes. We previously
showed a pivotal role for Nfix in regulating the tran-
scriptional switch from embryonic to fetal myogene-
sis. Here, we show that Nfix directly represses the
Myostatin promoter, thus controlling the proper
timing of satellite cell differentiation and muscle
regeneration.Nfix-null mice display delayed regener-
ation after injury, and this deficit is reversed upon
in vivo Myostatin silencing. Conditional deletion of
Nfix in satellite cells results in a similar delay in regen-
eration, confirming the functional requirement for
Nfix in satellite cells. Moreover, mice lacking Nfix
show reduced myofiber cross sectional area and a
predominant slow twitching phenotype. These data
define a role for Nfix in postnatal skeletal muscle
and unveil a mechanism for Myostatin regulation,
thus providing insights into the modulation of its
complex signaling pathway.
INTRODUCTION
Skeletal muscles play a critical role in voluntary movement, and
proper regeneration of this tissue after injury can be severely
compromised in a variety of contexts including neuromuscular
disorders. In vertebrates, muscle progenitors originating from
presomitic and cranial mesoderm give rise to ‘‘embryonic’’ or pri-
mary myogenesis, necessary to establish the basic muscle
pattern, and ‘‘fetal’’ secondary myogenesis, characterized by
growth and maturation of the muscle masses and by onset of
innervation (Biressi et al., 2007a). These two waves of myogen-
esis are mediated by distinct embryonic and fetal myoblasts,
respectively, each characterized by differentially expressed
genes and properties of the myoblasts as well as the differenti-
ated cells that they produce (Biressi et al., 2007b; Hutcheson2238 Cell Reports 14, 2238–2249, March 8, 2016 ª2016 The Authorset al., 2009). A key regulator of the embryonic and fetal classes
is Nuclear Factor I X (Nfix), which is abundant in the fetus and
almost absent in the embryo (Biressi et al., 2007b; Messina
et al., 2010). Nfix drives the transcriptional changes from embry-
onic to fetal myogenesis by specifically repressing embryonic
and activating fetal specific genes (Messina et al., 2010), and
its role is partially conserved during evolution (Pistocchi et al.,
2013).
Nfix is part of a family of highly conserved DNA-binding pro-
teins that function as transcriptional activators and/or repres-
sors: Nfia, Nfib, Nfic, and Nfix. NFI-binding sites are present in
the promoter, enhancer and silencer regions of many cellular
and viral genes (Kruse and Sippel, 1994), and NFI binding motifs
were detected in promoters of genes expressed in different or-
gans, such as brain (Bedford et al., 1998), lung (Bachurski
et al., 1997), liver (Jackson et al., 1993), intestine (Xu et al.,
2005), muscle (Spitz et al., 1997), connective tissue and skeletal
elements (Szabo´ et al., 1995).Nfix-null mice are characterized by
a reduced body size and inability to fully extend their limbs as
well as CNS and skeletal deficits (Campbell et al., 2008; Driller
et al., 2007). NFI binding sites are present in the promoters of
the differentiation geneMyogenin andmuscle-specific phospho-
fructo-kinase (Darville et al., 1992; Edmondson et al., 1992), and
they can form a complex with Myogenin, thus increasing their af-
finity for muscle-specific genes (Funk and Wright, 1992; Johan-
son et al., 1999).
Another critical regulator of prenatal and postnatal myogene-
sis is Myostatin, a secreted factor of the TGFb superfamily that
was shown to be a negative regulator of muscle size, where
loss-of-function mutations result in a dramatic increase in mus-
cle mass in different species including human (McPherron
et al., 1997; McPherron and Lee, 1997; Schuelke et al., 2004).
Although interference of this pathway was reported to lead to
functional improvement of dystrophic muscles in mice (Bogda-
novich et al., 2002), the precise mode of action of this powerful
signaling pathway as a potential therapeutic agent for myopa-
thies remains unclear. Notably, the contextual role of Myostatin
was highlighted, where in the embryo it regulates the balance be-
tween proliferation and differentiation of muscle progenitors
(Manceau et al., 2008), whereas in the adult, opposing roles in
Figure 1. Nfix Is Expressed by SCs and Its Absence Leads to a Reduced Myofiber Cross Sectional Area and to an Increased Slow MyHC
Expression
(A) Immunofluorescence analysis of Nfix expression (green) in Pax7+ SCs (red) on a Tibialis anteriormuscle section of aMlc3f-laczmouse, where myonuclei are in
purple (b-gal). Hoechst was used to stain nuclei (n = 4 mice). The scale bar represents 25 mm.
(B) H&E staining on Tibialis anterior muscles from WT and Nfix-null mice (n = 5 mice). The scale bar represents 100 mm.
(C) Graphical representation of the myofiber cross sectional area (CSA) in WT and Nfix-null muscles. The plotted values represent the distribution of n = 65
measurements on five random microscope fields (***p < 0.001 and two-tailed unpaired t test). The data are presented as mean ± whiskers from min to max.
(D) Western blot analysis of slow MyHC expression in WT and Nfix-null Soleus (SOL) and EDL muscles. The b-tubulin was used to normalize.
See also Figure S1.regulating myogenic differentiation have been reported (Langley
et al., 2002; Thomas et al., 2000; McCroskery et al., 2003; Taylor
et al., 2001).
Postnatal myogenesis is assured by satellite cells (SCs) that
are located between the basal lamina and the myofiber plasma
membrane (Mauro, 1961). Although they account for less than
5%of total muscle nuclei in adult muscles, they play an indispen-
sible role in the regeneration of adult skeletal muscle (Lepper
et al., 2011; McCarthy et al., 2011; Murphy et al., 2011; Relaix
and Zammit, 2012; Sambasivan et al., 2011).
Here, we report that absence of Nfix provokes an imbalance in
skeletal muscle homeostasis and regeneration. Moreover, we
identify Nfix as a regulator of Myostatin, where in vivo silencing
of Myostatin in regenerating Nfix-null muscles rescues the
regeneration defect. These findings have broad implications for
the understanding of pathways regulating postnatal myogenesis
and regeneration as well as providing insights into the role of
Myostatin as a critical regulator of skeletal muscle differentiation.
RESULTS
Altered Skeletal Muscle Phenotype in Nfix-Null Mice
We demonstrated previously that Nfix plays a critical role in the
switch from embryonic to fetal myogenesis (Messina et al.,
2010). Interestingly, Nfix-null mice are characterized by reduced
body size and inability to fully extend their limbs, suggesting aCepossible muscular phenotype (Driller et al., 2007). To explore
the role of Nfix in adult myogenesis, we examined its expression
and observed that both myonuclei and Pax7+ SCs express Nfix
(Figure 1A). Histological analysis of Nfix-null muscles showed
a marked reduction in the cross sectional area of myofibers,
although general muscle architecture remained normal
compared to wild-type littermates (Figures 1B and 1C). In addi-
tion, Nfix-null SC-derived myoblasts were able to differentiate
in vitro (Figure S1A), with no significant difference in proliferation
and apoptosis rates with respect to the wild-type (Figures S1B
and S1C). We reported previously that the embryonic marker
slow MyHC is negatively regulated by Nfix, through repression
of its activator Nfatc4 (Messina et al., 2010). Interestingly, adult
muscles lacking Nfix were characterized by an increased
expression of slow MyHC, which is evident in both typically
slow-twitching muscles (such as the Soleus) and fast-twitching
muscles (such as the EDL, Extensor Digitorum Longus) (Fig-
ure 1D). Notably, Nfix-null differentiated SC-derived myotubes
in vitro also expressed higher levels of slow MyHC compared
to wild-type (Figure S1D).
SC Differentiation and Muscle Regeneration Are
Delayed in the Absence of Nfix
To assess the role of Nfix during regeneration, we first examined
single muscle fibers isolated from wild-type and Nfix-null
mice. Freshly isolated wild-type and Nfix-null single fibers hadll Reports 14, 2238–2249, March 8, 2016 ª2016 The Authors 2239
comparable numbers of associated Pax7+ SCs (Figure S2A) and
after 24 hr in culture the number of MyoD expressing cells was
similar (Figure S2B). Analysis of SC proliferation and percentage
of MyoD expression during the first 12 hr in culture revealed no
difference between the two groups (Figures S2C and S2D).
Although no significant alterations in numbers of Pax7+ and
MyoD+ SCs were noted on Nfix-null myofibers, immunostaining
for MyoD and Myogenin on wild-type and Nfix-null myofibers
showed a marked reduction in the number of double Myod+/
Myogenin+ cells in absence of Nfix (Figures 2A and 2B). Notably,
this loss of differentiated cells in Nfix-null myofibers was more
pronounced after 72 hr in culture, suggesting a possible involve-
ment of Nfix during SCdifferentiation. Interestingly, the reduction
in Myogenin+ cells was less evident at later stages (Figure 2B),
thus suggesting a delay in muscle differentiation rather than a
general block of the differentiation process.
We reasoned that a delay in myogenic differentiation in
absence of Nfix could result in an altered regeneration in vivo.
We therefore injected the Tibialis anterior muscle of wild-type
and Nfix-null mice with the snake venom cardiotoxin (CTX)
to induce muscle regeneration. Following tissue damage, we
observed a striking delay in muscle regeneration after injury of
Nfix-null mice, as observed by persistent expression of develop-
mental MyHC (Collins et al., 2005; Sartore et al., 1982; Schiaffino
et al., 1986) (dMHC) expression (Figures 3A and 3D). In addition,
theNfix-null exhibited smaller regenerating myofibers compared
to wild-type (Figure S2E). Accordingly, Myogenin expression
was delayed and protracted in Nfix-null muscles (Figure 3B), in
keeping with our in vitro observations (Figures 2A and 2B).
Nevertheless, in spite of this altered timing, muscle regeneration
appeared complete at later time points in the Nfix-null (28 days
after injury, see Figure 3A). Interestingly, in Nfix-null mice, we
observed a marked upregulation of Myostatin, a potent inhibitor
of myogenesis, suggesting that this signaling pathway might be
involved in the delayed muscle regeneration phenotype (Fig-
ure 3B). This was most evident from day 5 after CTX injection
at a time when differentiation has already initiated, and it was
accompanied by the upregulation of the Myostatin downstream
effector phosphorylated Smad3 (pSmad3), particularly after
7 days (Figure 3C), suggesting a functional role for Myostatin
signaling. These results clearly indicate a role for Nfix in regu-
lating the proper timing of Myostatin expression and, in turn, of
muscle regeneration upon injury. Analysis of Myostatin expres-
sion in uninjured muscles revealed no difference between wild-
type and Nfix-null animals (data not shown), suggesting that
the upregulation of Myostatin expression specifically occurs as
a consequence of muscle injury.
Specific Deletion of Nfix in SCs Recapitulates the
Regeneration Defects
Since Nfix expression is not restricted to SCs, we investigated
muscle regeneration after CTX injury in tamoxifen treated
Tg:Pax7-CreERT2:Nfixfl/ mice (see Figure S3A) to examine the
specific role of Nfix in Pax7+ SCs. Tamoxifen treated Tg:Pax7-
CreERT2:Nfixfl/ mice were compared with both tamoxifen un-
treated mice and mice expressing only the Tg:Pax7-CreERT2
allele and treated with tamoxifen, as controls. To verify the effi-
cacy of tamoxifen treatment, sections of regenerating mouse2240 Cell Reports 14, 2238–2249, March 8, 2016 ª2016 The Authorsmuscles from each group were stained for Nfix. In both
Tg:Pax7-CreERT2:Nfix+/+ and tamoxifen untreated Tg:Pax7-
CreERT2:Nfixfl/ mice, all the centrally nucleated myofibers were
Nfix+, as expected (Figure S3C). In tamoxifen treated Tg:Pax7-
CreERT2:Nfixfl/mice, Nfix expression was completely abolished
in regenerating myonuclei, while it was still present in non-mus-
cle nuclei, thereby confirming the specificity of Tg:Pax7-CreERT2
deletion (Figure S3C). Efficiency of Nfix deletion was also
measured by counting the percentage of Pax7+ cells that had
excised Nfix and was calculated to be 96.2% ± 0.4 (Figure S3D).
Notably, tamoxifen treated Tg:Pax7-CreERT2:Nfixfl/ mice
showed a delayed regeneration when compared to both tamox-
ifen untreated floxed mice and tamoxifen treated Nfix+/+ mice
(Figure 4A). This defective regeneration was evident in tamoxifen
treated Tg:Pax7-CreERT2:Nfixfl/mice at 7 and 14 days post-CTX
injection where dMHC expression persisted, and H&E sections
revealed the continued presence of necrotic and inflammatory
areas (Figures 4A and S3E). Further, the analysis of Myogenin
clearly showed protracted expression in the tamoxifen treated
Tg:Pax7-CreERT2:Nfixfl/mice, confirming the delay in the regen-
erative process (Figure 4B). Finally, the distribution of the cross
sectional area of regeneratingmyofibers in the three groups sup-
ports the delayed regeneration phenotype of tamoxifen treated
Tg:Pax7-CreERT2:Nfixfl/mice, mostly evident after 14 days (Fig-
ure S3B). These data support the specific function of Nfix in SCs
for proper timing of Myogenin expression as well as the regener-
ation process.
Nfix Regulates Myostatin Expression in Differentiating
Myoblasts
In keeping with the observation that Nfix-null mice exhibit de-
layed muscle regeneration, Myostatin expression was upregu-
lated in the absence of Nfix (Figure 3B). Since Myostatin is a
TGF-b family member with anti-myogenic properties (Elliott
et al., 2012), its upregulation can explain the delayed regenera-
tion observed in mice lacking Nfix. To address this point, we
investigated the possibility that Nfix might directly regulate Myo-
statin expression in differentiating myoblasts. First, we analyzed
Myostatin expression in differentiating SC-derived myoblasts.
As shown in Figure 5A, Nfix acts as a suppressor of Myostatin
in differentiating myoblasts, even in absence of the contribution
of the myofiber.
For biochemical analysis, we validated this result using the
C2C12 myogenic cell line. C2C12 cells were transduced with a
lentiviral vector carrying a small hairpin RNA targeting Nfix
(shNfix) or a scrambled sequence as a control (scramble). The
transduction effectively resulted in the downregulation of Nfix
expression in shNfix-treated C2C12, as confirmed by western
blot (Figure 5B). Importantly, Myostatin expression was upregu-
lated in Nfix-silenced myotubes starting from day 5, confirming
that Nfix was able to downregulate Myostatin expression in
differentiating C2C12 myoblasts (Figure 5C).
Nfix can bind with high affinity to the palindromic consensus
sequence TTGGC(N5)GCCAA (Kruse and Sippel, 1994),
although NFI factors can also bind to hemi-binding sites (a single
TTGGC or GCCAA site alone) (Gronostajski, 2000) with a lower
affinity. In silico analysis using Genomatix Software allowed us
to identify hypothetical Nfix hemi-binding sites in the Myostatin
Figure 2. SCs Lacking Nfix Are Characterized by a Delayed Differentiation
(A) Immunofluorescence analysis of MyoD (green) and Myogenin (Myog, red) expression on single muscle fibers from WT and Nfix-null muscles after 24, 48, 72,
and 96 hr in culture. Hoechst was used to stain nuclei (n = 3 WT and 3 Nfix-null mice). The scale bar represents 50 mm.
(B) Quantification of MyoD+/Myogenin+ and MyoD+/Myogenin SCs associated with WT and Nfix-null myofibers at 24, 48, 72, and 96 hr in culture. The
quantification is the result of three independent experiments on three WT and three Nfix-null mice. The data are presented as mean ± SD (not significant, ns;
***p < 0.001 with n = 11 WT myofibers and n = 16 Nfix-null myofibers; and two-tailed unpaired t test).
See also Figure S2.
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Figure 3. Absence of Nfix Leads to a Marked Impairment of Muscle Regeneration after Injury
(A) Immunofluorescence for dMHC (green) on regenerating WT and Nfix-null Tibialis anterior muscles 5, 7, 10, 14, and 28 days (d) following CTX injection. The
laminin is marked in red and Hoechst was used to stain nuclei (n = 3 mice for each group). The scale bar represents 50 mm.
(B) Western blot analysis of Myogenin and Myostatin expression on WT and Nfix-null muscles 3, 5, 10, and 28 days (d) following CTX injection. The b-tubulin was
used to normalize.
(C) Western blot analysis of pSmad3 and Smad3 expression onWT andNfix-null muscles 5 and 7 days (d) following CTX injection. GAPDHwas used to normalize.
(D) Quantification of the percentage of dMHC positive myofibers in WT and Nfix-null mice after 7 and 14 days following CTX injection (n = 6 mice for time point 7
and n = 5 mice for time point 14). The data are presented as mean ± SD (*p < 0.05; **p < 0.01; and two-tailed unpaired t test).
See also Figure S2E.promoter that were used to design specific primers. Notably, the
identified sites are flanked by putative binding sites for MEF-2,
which is a known co-factor of Nfix (Messina et al., 2010).
To assess whether Nfix can bind directly and regulate the My-
ostatin promoter, we performed a chromatin immunoprecipita-
tion (ChIP) assay on differentiating C2C12. Proliferating C2C12
myoblasts were transduced with a HA-tagged Nfix2 lentiviral
vector and then ChIP analysis was performed after 4 days in dif-
ferentiation medium on the identified Nfix binding domains of
Myostatin promoter. As expected, Nfix bound to the Nfatc4 pro-
moter as described previously (Messina et al., 2010), and it was
also found to directly bind to Myostatin promoter (Figure 5D). To2242 Cell Reports 14, 2238–2249, March 8, 2016 ª2016 The Authorsdetermine how Nfix binding affected Myostatin expression, we
transduced wild-type and Nfix-null SC-derived myoblasts with
a Nfix2-HA lentivirus. A significant decrease inMyostatin expres-
sion was noted following Nfix overexpression, both in wild-type
and in Nfix-null myoblasts (Figure 5E), thereby confirming the
repressive role of Nfix on Mstn expression.
In Vivo Silencing ofMyostatin Rescues theRegeneration
Delay in Nfix-Null Mice
From the results indicated above, we predicted that regeneration
defects observed inNfix-null mice would be rescued by reducing
Myostatin expression. Due to lethality of perinatal mice and
Figure 4. Absence of Nfix in SCs Deter-
mines the Delay in Muscle Regeneration
(A) H&E staining and immunofluorescence for
dMHC (green) on transverse sections of re-
generating Tibialis anteriormuscles from Tg:Pax7-
CreERT2:Nfix+/+ and Tg:Pax7-CreERT2:Nfixfl/mice
with (TMX) or without (NO TMX) tamoxifen treat-
ment. The muscles were collected and stained
after 5, 7, and 14 days (d) from CTX injection. The
laminin is marked in red and Hoechst was used to
stain nuclei (n = 3 mice for each group). The scale
bar represents 100 mm.
(B) Western blot analysis of Myogenin expres-
sion on regenerating muscles from Tg:Pax7-
CreERT2:Nfix+/+ (Nfix+/+) and Tg:Pax7-CreERT2:
Nfixfl/ mice (Nfixfl/) with (TMX) or without (NO
TMX) tamoxifen treatment after 3, 5, 7, and
14 days (d) from CTX injection. Myogenin and
GAPDH in the right panel come from two separate
gels but using the same samples and protein
amount. GAPDH was used to normalize.
See also Figure S3.difficulties in obtaining viable Nfix:Mstn double-null mice, we
electroporated wild-type and Nfix-null regenerating Tibialis
anterior muscles with control plasmids (scramble) or plasmids
carrying an shRNA targeting Mstn (shmstn). Initial studies were
carried out to verify the correct downregulation of Mstn expres-
sion after electroporation of the shmstn plasmid both in entire
muscles and in re-isolated myoblasts (Figures S4A and 6C).
We then electroporated scramble and shmstn plasmids 4 days
after muscle injury, to obtain the maximal downregulation of
Myostatin around day 6, which corresponds to the temporal win-
dow in which Myostatin was upregulated in Nfix-null mice (Fig-
ure 3B). Muscles were then isolated and processed at different
time points after injury. Remarkably, we obtained a rescue of
the regeneration defects of Nfix-null mice in muscles treated
with the shmstn plasmid, but not with the scramble control vec-Cell Reports 14, 2238–224tor (Figure 6A). This was particularly
evident at 14 days after muscle injury,
as shown by analysis of muscle sections
stained for dMHC. The differences
observed were even more striking in total
muscle section reconstructions (Fig-
ure S4C). The analysis of the cross
sectional area of regenerating myofibers
revealed, as expected, a reduced cross
sectional area for Nfix-null muscles with
respect to wild-type. However, the regen-
erative delay phenotype was rescued
upon Myostatin silencing; shmstn treated
Nfix-null myofibers were comparable
in size to scramble-treated wild-type
(WT) fibers at the same time points (Fig-
ure S4B). This result highlights Myostatin
involvement in the regeneration defects
of Nfix-null mice, although from this
experiment we cannot rule out the contri-
bution of Myostatin to Nfix-null myofibersize in resting conditions. Strikingly, the regeneration rescue
is supported by quantification of dMHC, whose expression
was significantly reduced as a consequence of Myostatin
silencing in Nfix-null mice (Figure 6B).
DISCUSSION
Developmental and regenerative myogenesis share common
and distinct features. Previous work from our group demon-
strated that Nfix is responsible for the transcriptional switch
from embryonic to fetal myogenesis during prenatal develop-
ment (Messina et al., 2010). In the present study, we show that
Nfix is required for maintaining muscle physiology postnatally
and for the proper timing of muscle regeneration, where we
report a link between Nfix and Mstn expression. Notably, the9, March 8, 2016 ª2016 The Authors 2243
Figure 5. Nfix Regulates Myostatin Expression in Differentiating Myoblasts through a Direct Binding to its Promoter
(A) Real-time qPCR showingMyostatin upregulation in differentiating SC-derivedmyoblasts. The SCswere isolated by FACS and plated in differentiationmedium
for a time course analysis from 1 to 3 days (DM1, DM2, and DM3) (n = 4 DM1WT, n = 2 DM1Nfix-null, n = 5 DM2WT, n = 3 DM2Nfix-null, n = 4 DM3WT, and n = 4
DM3 Nfix-null). The data are presented as mean ± SD (not significant, ns; *p < 0.05; **p < 0.01; and two-tailed unpaired t test).
(B) Western blot analysis of Nfix expression in C2C12 myoblasts transduced with a control vector (C2C12 scramble) or with a vector carrying a shRNA targeting
Nfix (C2C12 shNfix). GAPDH was used to normalize.
(C) Real-time qPCR analysis of Myostatin expression in scramble and shNfix C2C12 in a time course from 3 to 7 days in differentiation medium. The values are
plotted as relative expression and normalized to GAPDH (n = 3 independent samples for each time point). The data are presented as mean ± SD (not significant,
ns; *p < 0.05; **p < 0.01; and two-tailed unpaired t test).
(D) ChIP on differentiated C2C12 transduced with a vector expressing a HA-tagged Nfix2 isoform to test binding to putative Nfix binding sites on Myostatin
promoter located at87/212 bp and274/548 bp from transcription start site. Binding on Nfatc4 promoter and on an intergenic region were used as positive
and negative controls, respectively. The data are means of two independent experiments and expressed as fold enrichment (mean ± SD) relative to the IgG signal
(n = 3 independent ChIP).
(E) Real-time qPCR for Myostatin in WT andNfix-null SC-derivedmyoblasts transduced with a control vector (scramble) or with a vector overexpressing the Nfix2
isoform (Nfix2-HA). The values are plotted as relative expression and normalized to GAPDH (n = 3 samples for each group). The data are presented as mean ± SD
(*p < 0.05; **p < 0.01; and two-tailed unpaired t test).absence of Nfix leads to a dramatic delay in muscle regeneration
in vivo, and this phenotype can be rescued by suppressingMstn
expression.
One of themain features that we observed inNfix-null muscles
was an altered muscular physiology characterized by a strikingly
reduced muscle fiber size and an overexpression of the slow
MyHC isoform. As already observed during prenatal develop-2244 Cell Reports 14, 2238–2249, March 8, 2016 ª2016 The Authorsment, the ability of Nfix to modulate slow MyHC expression is
maintained after birth. Since Nfix plays important roles in brain
and CNS development (Campbell et al., 2008), those pheno-
types might directly or indirectly impact on the muscle pheno-
types reported here. However, we show that upregulation of
slow MyHC in the absence of Nfix is reproducible in SC-derived
myotubes in culture, thus suggesting that the phenotype
Figure 6. In Vivo Silencing of Myostatin in Regenerating Nfix Null Muscles Rescues their Regeneration Defects
(A) Immunofluorescence analysis of dMHC expression (green) on regenerating WT and Nfix-null Tibialis anterior muscles after muscle electroporation with a
control plasmid (scramble) or with a plasmid carrying an shRNA targeting Myostatin (shmstn). The muscles were electroporated after 4 days following CTX
injection and were collected and stained after 7, 10, and 14 days (d) following CTX injection. The laminin is marked in red and Hoechst was used to stain nuclei
(n = 3 mice for each group). The scale bar represents 100 mm.
(B) Quantification of the percentage of dMHC positive myofibers in Nfix-null mice electroporated with scramble or shmstn plasmids after 7 and 14 days following
CTX injection (n = 5 mice for each group). The data are presented as mean ± SD (*p < 0.05 and two-tailed unpaired t test).
(C) Real-time qPCR showing Myostatin expression in myoblasts re-isolated from Tibialis anterior electroporated with control (scramble) or shMyostatin (shMstn)
plasmids. The myoblasts were isolated the day after in vivo transfection, and cultures were stopped 2 days later to perform qRT-PCR. The data are presented as
mean ± SD.
See also Figure S4.observed is cell-autonomously dependent on Nfix function in
muscle. Moreover, ChIP experiments on C2C12 confirmed Nfix
binding to Nfatc4 promoter, further suggesting that the mecha-
nism of action is conserved between prenatal and postnatal life.CeWe also noted delayed differentiation of single fiber-associ-
ated myogenic cells that is accompanied by the modulation
of Myogenin expression. This finding is consistent with the
marked delay in regeneration observed in Nfix-null mice.ll Reports 14, 2238–2249, March 8, 2016 ª2016 The Authors 2245
Importantly, in addition to the persistent expression of dMyHC
and to a delayed expression of Myogenin we observed a
sustained expression of Mstn in injured muscles of Nfix-null
mice. Myostatin (GDF8) is a potent inhibitor of myogenesis,
where a dramatic increase in muscle mass was reported in
Mstn-null mice (McPherron et al., 1997). However, the mode
of action of Myostatin remains under debate for both prenatal
and postnatal myogenesis (Manceau et al., 2008). Here, we
show that the increased expression of Mstn in both Nfix
silenced differentiating C2C12 cells and SC-derived myo-
blasts, as also in Nfix-null regenerating muscles, correlates
with the delayed differentiation in vitro and in injured muscles.
Myostatin is known to inhibit myoblast differentiation through
inhibition of SC activation and proliferation (McCroskery et al.,
2003; Taylor et al., 2001) and through repression of MyoD ac-
tivity (Langley et al., 2002). Moreover, inhibition of Myostatin is
known to accelerate muscle regeneration (McCroskery et al.,
2005), thus supporting a causative relationship between the
increase in Myostatin levels that we observed in regenerating
Nfix-null mice and the delayed regeneration that characterizes
them. We note that differences between WT and Nfix-null
mice are apparent in muscles from day 5 after CTX injection,
coinciding with the first difference in Mstn expression. More-
over, in vivo silencing of Mstn in adult Nfix-null muscles
resulted in recovery of the correct timing of muscle regenera-
tion after injury, confirming the causative relationship be-
tween Mstn sustained expression and the delayed regenera-
tion observed in mice lacking Nfix. Importantly, the delayed
regeneration was observed also in tamoxifen treated
Tg:Pax7-CreERT2:Nfixfl/ mice, supporting the central role
played by Nfix in SCs. Accordingly, isolated SC-derived
Nfix-null myotubes express higher levels of Myostatin during
differentiation and this is reversed upon Nfix re-expression.
We therefore identified a mechanism of action for Nfix by
showing that it can act as a direct regulator of Mstn. In light
of contradictory reports on the mode of action of Myostatin,
it is important to underscore the potentially distinct contextual
roles of Myostatin (Manceau et al., 2008). Similar to the
contextual roles for Notch signaling in adult myogenesis
(Mourikis et al., 2012a, 2012b; Rios et al., 2011), recent
studies suggest that Myostatin is necessary to regulate to
proper balance between proliferation and differentiation of
progenitor cells (George et al., 2013; Manceau et al., 2008;
McCroskery et al., 2003).
Here, we suggest that Mstn regulation is temporally
controlled for appropriate muscle differentiation and regen-
eration. Forced Mstn expression or silencing would inevitably
led to a complete block in regeneration or to an accele-
rated differentiation at the expense of the proper muscle
physiology.
In summary, this work demonstrates that Nfix acts through an
inhibitory mechanism at the Mstn promoter in differentiating
myoblasts, thereby influencing the commitment of SCs during
differentiation and the proper timing of muscle regeneration.
The mechanism identified not only broadens our knowledge on
the function of Nfix in postnatal skeletal myogenesis, but also
contributes to our understanding of molecular mechanisms
involved in the regulation of Mstn.2246 Cell Reports 14, 2238–2249, March 8, 2016 ª2016 The AuthorsEXPERIMENTAL PROCEDURES
Animal Models
Nfix-null micewere generated crossing heterozygousmice obtained fromProf.
Richard M. Gronostajski (University of Buffalo) and were always compared to
WT littermates or age-matched WT mice. To increase Nfix-null mice survival,
their food was supplemented with a soft dough chow (Transgenic Dough
Diet, Bioserv) starting from postnatal day (P)21, as described (Campbell
et al., 2008). WT mice used as controls were fed with the same diet.
Tg:Pax7-CreERT2mice were described previously (Mourikis et al., 2012b).Nfixfl
mice were obtained fromProf. RichardM. Gronostajski (Campbell et al., 2008).
Mouse genotyping was performed by PCR (GoTaq DNA Polymerase,
Promega) using the primers listed in Table S1. For muscle regeneration,
20 ml of 100 mM CTX from Naja mossambica (Sigma-Aldrich) were injected in
the Tibialis anterior of 2-month-old mice. Induction of Nfix deletion in
Tg:Pax7-CreERT2:Nfixfl/ was performed by multiple tamoxifen injections.
Starting from P18, mice received three subcutaneous injections (one every
24 hr for 3 days) of 50 mg tamoxifen (20 mg/ml) per gram of mouse. At
1 week before CTX, mice were subjected to an intraperitoneal injection of
25 mg/ml tamoxifen (250 mg per gram of mouse). Starting from the day after,
mice were fed with a specific tamoxifen enriched or control diet (Harlan). A
detailed scheme of tamoxifen treatment is described in Figure S3A.
Mice were kept in pathogen-free conditions and all procedures were con-
formed to Italian law (D. Lgs n 2014/26, implementation of the 2010/63/UE)
and approved by the University of Milan Animal Welfare Body and by the Italian
Minister of Health.
Measurement of Myofiber Cross Sectional Area
Cross sectional area of the myofibers was calculated on section images
obtained from Tibialis anterior muscles using ImageJ.
Cell Culture
C2C12 cells (ATCC) were cultured at 37C, 5% CO2 in DMEM (Lonza) plus
20% fetal bovine serum (FBS) (Lonza), 2 mM L-Glutamine (Sigma-Aldrich),
and 1% Penicillin/Streptomycin (Euroclone). Differentiation was induced
plating 1.5 3 105 cells in 35 mm petri dishes with DMEM, 2% horse serum
(Lonza), 2 mM L-Glutamine and 1% Penicillin/Streptomycin.
SC Isolation and Culture
SCs (myoblasts) were isolated from WT and Nfix-null mice at P7–P10. Fore-
limb, hindlimb, and diaphragm muscles were dissected, mechanically cut,
and enzymatically digested at 37C under constant shaking with a solution
containing Collagenase I (100 mg/ml, Sigma-Aldrich), Dispase (500 mg/ml,
Gibco), and DNaseI (100 mg/ml, Roche) in PBS (Sigma-Aldrich). Undigested
tissue was precipitated for 5 min, and the supernatant was centrifuged for
5 min at 1,200 g. The cell pellet was resuspended in DMEM plus 10% FBS,
3% chick embryo extract, 2 mM L-Glutamine, 1% Penicillin/Streptomycin
and preplated in 150 mm petri dishes for 1 hr. After pre-plating, the non-
adherent, myoblast enriched population was collected and plated in collagen
coated (Collagen from calf skin, Sigma-Aldrich) 90mmpetri dishes at a density
of 15,000 cells per petri. After a few days in proliferation, the myoblasts were
eventually plated at high density (250,000 cells in 35 mm dishes) in differenti-
ation medium (DMEM, 5%horse serum, 2mML-Glutamine, and 1%Penicillin/
Streptomycin).
For cell sorting experiments, tissueswere processed similarly, and then cells
were blocked with 10% donkey serum (Sigma-Aldrich) in PBS for 15 min at
room temperature (RT). The cells were incubated 30 min on ice with primary
antibody detecting SM/C-2.6 antigen, biotinylated, 1:200 (Fukada et al.,
2004). After two washes, cells were incubated with Streptavidin-APC (BD
Pharmingen, 1:500) and CD45-FITC (Rat Anti-Mouse, 30-F11, BD Pharmin-
gen, 1:100), 20 min on ice. The cells were washed again and sorted with a
MoFlo XDP cell sorter (Beckman Coulter) based on positivity for SM/C-2.6
antigen and negativity for CD45.
BrdU Incorporation
For BrdU incorporation, 3 3 104 SC-derived myoblasts were plated in 35 mm
petri dishes. The cells were exposed for 1 hr to 50 mm BrdU (Amersham). The
cells were then fixed with 95% EtOH-5% acetic acid (VWR) for 20 min at RT,
incubated with PBS-1.5 M HCl (VWR) for 10 min at RT, washed twice with
PBS, and permeabilized with 0.2% Triton in PBS. Primary antibody (1:100,
anti-Bromo-deoxyuridine clone BU-1, Amersham) was incubated for 1 hr at
4C. After four washes, secondary antibody (1:500) was incubated with
Hoechst for 40 min at RT. The cells were washed twice with PBS before
mounting.
ELISA Assay for Caspase 9 Concentration
Measurement of the apoptosis rate was performed with an ELISA kit for the
detection of mouse Caspase-9 concentration (Cusabio Biotech), according
to manufacturer’s instructions. Data were acquired with a spectrophotometer
(wavelength 450 nm, Tecan). Calculation of results was performed using Curve
Expert software.
Single Fiber Isolation and Culture
Single muscle fibers were isolated from gastrocnemius and quadriceps mus-
cles as previously described (Rosenblatt et al., 1995). In brief, muscles were
enzymatically dissociated with 0.2% Collagenase I (Sigma-Aldrich) in DMEM
for 30min at 37Cwith constant rolling. Single fibers were isolated under a ste-
reomicroscope by gently passing through fire-polished Pasteur pipettes with
different sized apertures. Purified single fibers were transferred in new plates
with SC growth medium, cultured at 37C, 5% CO2, and fixed for staining
with 4% paraformaldehyde every 24 hr from 0 to 96 hr. EdU incorporation
and staining were performed using the Click-iT EdU Alexa Fluor 594 Imaging
Kit (Life Technologies), according to manufacturer’s instruction.
Lentiviral Transduction
C2C12 myoblasts were transduced with a lentivirus carrying a scrambled
sequence or a shNfix. Transduction was performed in suspension (in DMEM
20% FBS), at a MOI of 100 and in the presence of Polybrene (8 mg/ml,
Sigma-Aldrich). After overnight (O/N) incubation, the medium was changed,
and cells were treated with puromycin (2 mg/ml, Sigma-Aldrich). SC-derived
myoblasts and C2C12 used for ChIP experiments were transduced with a
lentiviral vector carrying a control sequence or a Nfix2-HA-tagged isoform,
described in Messina et al. (2010).
Immunofluorescence and Histology
Muscles were isolated from tendon to tendon, rapidly passed in liquid nitro-
gen-cooled isopentane (VWR) for 1 min, then in liquid nitrogen for 2 min, and
left at 80C until processed. There were 7 mm sections that were cut with a
cryostat (Leica) on positively charged glass slides (Superfrost Plus, Thermo
Scientific). Muscle sections were stained with H&E (Sigma-Aldrich) according
to standard protocols. For immunofluorescence analysis, cells or sections
were fixed for 10 min with 4% paraformaldehyde in PBS at 4C (apart from
staining for dMHC that do not require fixation). Samples were then permeabi-
lized with 1% BSA (Sigma-Aldrich)-0.2% Triton X-100 (Sigma-Aldrich) in PBS
for 30min and blockedwith 10% goat serum (Sigma-Aldrich) in PBS for 30min
at RT. Primary antibodies were incubated O/N at 4C in PBS. After two washes
with PBS-1% BSA-0.2%Triton, samples were incubated with secondary anti-
bodies (1:500, Jackson Laboratory. Fluorochromes used: 488, 649, 594, and
546) andHoechst (1:500, Sigma-Aldrich) in PBS for 45min at RT, washed twice
with PBS-0.2% Triton and mounted with Fluorescence Mounting Medium
(Dako).
Immunofluorescences on single fibers were performed in suspension.
Single myofibers were collected in 1.5 ml tubes and fixed for 10 min with
4% paraformaldehyde in PBS at 4C. Fixed myofibers were treated with
PBS-1% Triton-10% goat serum for 30 min at RT. Primary antibodies were
incubated O/N in PBS-1% goat serum. After two washes with a solution con-
taining 1% BSA in PBS, single myofibers were incubated with secondary
antibodies and Hoechst in PBS for 1 hr at RT, washed twice with PBS-1%
BSA, and mounted on slides.
Images were acquired at RT using a Leica-DMI6000B fluorescence micro-
scope equipped with 103 and 203magnification objectives. Leica DFC365FX
or DFC400 cameras were used for image capture. The Leica Application Suite
software was used for acquisition. Single channel pictures were merged using
Photoshop. The following primary antibodies and dilutions were used: rabbitCeanti-Nfix (1:200, Novus Biologicals); chicken anti-laminin (1:500, Abcam); rab-
bit anti-laminin (1:300, Sigma-Aldrich); mouse anti Pax7 (1:2, DSHB); mouse
anti-total MyHC (MF20) (1:2, DSHB); chicken anti-b-gal (1:500, Abcam); mouse
anti-dMHC, which detects the Myh3 isoform (1:40, Monosan); rabbit anti-
MyoD (C-20) (1:60, Santa Cruz Biotechnology); and mouse anti-Myogenin
(1:3, DSHB).
RNA Extraction, RT-, and Real-Time qPCR
Total RNA from cultured cells was extracted using the NucleoSpin kits RNA XS
and II (Macherey-Nagel). Isolation of total RNA from muscles was performed
with TRIzol Reagent (Invitrogen) according to the manufacturer’s instructions.
RNA was quantified using a NanoPhotometer (Implen). There was 1 mg of total
RNA for each sample that was retrotranscribed with the iScript Reverse
Transcription Supermix for RT-quantitative (q)PCR (Bio-Rad) in a total volume
of 20 ml. For qRT PCR, cDNA was diluted 1:10 and 5 ml of the diluted cDNA
was loaded in a total volume of 20 ml (iTaq Universal, Bio-Rad). Primers used
are listed in Table S2. The relative quantification of gene expression was
determined by comparative CT method, and normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH).
ChIP Assay
For ChIP, 3.53 106 scramble C2C12myoblasts per antibody were plated. The
cells were maintained in culture for 1 day in DMEM, 20% FBS, and then
induced to differentiate with DMEM, 2% horse serum, at a density of 1.5 3
106 cells in 90 mm petri dishes. Crosslink was performed at day 4 in differen-
tiation with 1% formaldehyde (Sigma-Aldrich) in DMEM for 10 min. Crosslink
was blocked with 0.125 M Glycine (Sigma-Aldrich) in PBS for 10 min while
shaking. After two washes with PBS, cells were scraped with PBS containing
protease inhibitors and phenylmethanesulfonyl fluoride (PMSF) and centri-
fuged for 15 min at 1,500 g at 4C. The cell pellet was dounced 20 times in a
7 ml pestle in swelling buffer, then centrifuged for 10 min at 5,000 g at 4C,
and the nuclei pellet was sonicated with a Bioruptor Sonicator (Diagenode)
for 15 min, with repeated cycles of 15 s of sonication and 15 s of resting. Sam-
ples were finally centrifuged for 10 min at 12,000 g at 4C, and chromatin-
enriched supernatant was used in the following passages. Chromatin was
pre-cleared for 2 hr with Protein G Sepharose (PrG, 15 ml per sample)
(Amersham) and rabbit serum (2.5 ml per sample) and for 2 hr with PrG
previously blocked with BSA (10 mg/ml) and Salmon Sperm (1 mg/ml)
(Sigma-Aldrich) on a rotating platform at 4C. Chromatin was than incubated
O/N with primary antibodies. The day after, immunocomplexes were precipi-
tated by addition of blocked PrG for 3 hr on rotating platform at 4C, then
centrifuged for 2 min at 12,000 g at 4C. Samples were then repeatedly
washed and the antibody-protein-DNA complexes were eluted twice for
10 min at 65C. Eluted samples were incubated O/N at 65Cwith 10 mg RNase
(Sigma-Aldrich) and 200 mM NaCl (Sigma-Aldrich) to reverse crosslinks.
Finally, DNA was treated with Proteinase K (Sigma-Aldrich) (20 mg per sample)
for 3 hr at 50C and then extracted with phenol-chloroform. Obtained DNA
samples were analyzed with qPCR and results were plotted as fold enrichment
with respect to the IgG sample. Primers used are listed in Table S3.
There were 5 mg of the following primary antibodies that were used: rabbit
anti-HA-probe (Y-11, Santa Cruz Biotechnology); normal rabbit IgG (Santa
Cruz Biotechnology).
Western Blot
Total protein extracts were obtained from cells or homogenized tissues, lysed
with RIPA or Tissue extraction buffer plus protease and phosphatase inhibitors
for 30 min on ice. Samples were then centrifuged 10 min at 12,000 x g at 4C,
and the supernatant transferred into a new tube and quantified using the DC
Protein Assay (Bio-Rad). There were 30 mg of total protein extracts that were
loaded on a 7%–12% SDS (Sigma-Aldrich) acrylamide gel (Sigma-Aldrich)
and blotted to a nitrocellulose membrane (Whatman, Protran Nitrocellulose
Transfer Membrane). After 1 hr of blocking in milk, primary antibodies were
incubated O/N. Blots were then washed and incubated with secondary anti-
bodies (1:10,000, IgG-HRP, Bio-Rad) for 40 min at RT and washed again.
Finally, bands were revealed with ECL detection reagent (Amersham) and
exposed to an X-ray film (Hyperfilm ECL, Amersham). In some cases, blots
were acquired using the Chemidoc software (Bio-Rad).ll Reports 14, 2238–2249, March 8, 2016 ª2016 The Authors 2247
The following primary antibodies and dilutions were used: rabbit anti-Nfix
(1:5,000, Geneka Biotechnology); mouse anti-b-tubulin (1:5,000, Covance);
mouse anti-slow MyHC (Bad5, 1:2, DSHB); mouse anti-total MyHC (MF20,
1:5, DSHB); mouse anti-Myogenin (IF5D, 1:3, DSHB); rabbit anti-Myostatin
(1:500, Millipore); mouse anti-GAPDH (1:5,000, Sigma-Aldrich); rabbit anti-
Smad3 (1:1,000, Abcam); rabbit anti-pSmad3 (1:1,000, Abcam).
In Vivo Electroporation
In vivo electroporation was performed 4 days after CTX injection. WT and
Nfix-null mice were anesthetized and 40 mg of control (scramble, Sigma-
Aldrich), or shmstn (Sigma-Aldrich) plasmids were injected in a total volume
of 20 ml in Tibialis anteriormuscles. Muscles were then immediately electropo-
rated using a pulse generator (ECM 830, BTX) equipped with 5 mm needle
electrodes to generate 100 V pulses, with a fixed duration of 20 ms and an
interval of 200 ms between the pulses.
Statistical Analysis
All data are expressed as mean ± SD. Data were graphed using GraphPad
Prism and analyzed with the two-tailed unpaired Student’s t test. *p < 0.05;
**p < 0.01; ***p < 0.001; and confidence intervals 95%, alpha level 0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and three tables and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2016.02.014.
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